Literature DB >> 11580136

Scavenger cells with gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis.

K Tsuneyama1, K Harada, N Kono, K Hiramatsu, Y Zen, Y Sudo, M E Gershwin, M Ikemoto, H Arai, Y Nakanuma.   

Abstract

BACKGROUND/AIMS: Gram-positive bacterial DNA is frequently detectable in gallbladder bile of primary biliary cirrhosis (PBC) patients. To advance these findings, lipoteichoic acid (LTA) of gram-positive bacteria with high antigenicity was examined in liver specimens and bile from PBC patients and controls.
METHODS: LTA was examined by Western blotting in the gallbladder bile from 15 PBC, 11 cholecystolithiasis and six normal subjects, and by immunohistochemistry in liver specimens from 16 PBC, six primary sclerosing cholangitis (PSC), eight chronic viral hepatitis C (CVH-C) and five normal subjects.
RESULTS: In the gallbladder bile, there was no significant difference in the positive rate of LTA between PBC and controls. LTA-containing mononuclear cells were frequently detected in the portal tracts, particularly around the bile ducts and in hepatic sinusoids in PBC, while they were infrequent or occasional in control livers. These LTA-containing cells were sinusoidal endothelial cells and Kupffer cells, and portal monocytes, which frequently expressed scavenger receptor class B type 1.
CONCLUSIONS: LTA derived from bacterial fragments may reach the bile, not only in the diseased state but also under normal conditions. Such LTA may be involved in the development and progression of portal tract lesions, particularly bile duct lesions, in PBC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580136     DOI: 10.1016/s0168-8278(01)00084-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

Review 1.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

2.  ATP-binding cassette sterol transporters are differentially expressed in normal and diseased human gallbladder.

Authors:  Jai Hoon Yoon; Ho Soon Choi; Dae Won Jun; Kyo-Sang Yoo; Jin Lee; Sun Young Yang; Rahul Kuver
Journal:  Dig Dis Sci       Date:  2012-11-22       Impact factor: 3.199

Review 3.  Pathogenesis of primary biliary cirrhosis: a unifying model.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

4.  Cutting edge issues in primary sclerosing cholangitis.

Authors:  Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 5.  The immunology of primary biliary cirrhosis: the end of the beginning?

Authors:  J M Palmer; J A Kirby; D E J Jones
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

6.  CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells.

Authors:  Tatyana G Vishnyakova; Roger Kurlander; Alexander V Bocharov; Irina N Baranova; Zhigang Chen; Mones S Abu-Asab; Maria Tsokos; Daniela Malide; Federica Basso; Alan Remaley; Gyorgy Csako; Thomas L Eggerman; Amy P Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-27       Impact factor: 11.205

Review 7.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

Review 8.  Biliary innate immunity: function and modulation.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Mediators Inflamm       Date:  2010-07-27       Impact factor: 4.711

9.  Cholangiopathy with respect to biliary innate immunity.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2011-08-11

10.  Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis.

Authors:  Carlo Selmi; Anna Maria Papini; Piera Pugliese; Maria Claudia Alcaro; M Eric Gershwin
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.